A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
Clinical trial NCT00219115 · COMPLETED
Trial details
- NCT number
- NCT00219115
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2006-03-01
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.